Korea Investment Corp
RGNX icon

Korea Investment Corp’s Regenxbio RGNX Stock Holding History

Korea Investment Corp’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-393,071
Closed -$16.5M – 749
2021
Q3 		$16.5M Sell
393,071
-62,900
-14% -$2.26M 0.05% 282
2021
Q2 		$17.7M Sell
455,971
-11,900
-3% -$426K 0.05% 283
2021
Q1 		$16M Sell
467,871
-22,100
-5% -$943K 0.05% 280
2020
Q4 		$22.2M Buy
489,971
+44,300
+10% +$1.55M 0.07% 242
2020
Q3 		$12.3M Sell
445,671
-49,400
-10% -$1.61M 0.04% 310
2020
Q2 		$18.2M Buy
495,071
+7,600
+2% +$283K 0.07% 251
2020
Q1 		$15.8M Buy
487,471
+31,900
+7% +$1.33M 0.07% 250
2019
Q4 		$18.7M Buy
455,571
+17,600
+4% +$695K 0.07% 275
2019
Q3 		$15.6M Buy
437,971
+35,500
+9% +$1.44M 0.07% 283
2019
Q2 		$20.7M Buy
+402,471
New +$20.1M 0.09% 235

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Korea Investment Corp's RGNX Position: Q4 2021 in Review

Korea Investment Corp sold out of Regenxbio (RGNX) in Q4 2021, closing a stake of 393,071 shares — an estimated $16.5M sold.

Korea Investment Corp first reported a position in RGNX in Q2 2019 and held it in 10 quarters. The position peaked at $22.2M in Q4 2020. 172 funds tracked by Wall St. Rank hold RGNX as of Q4 2021.

  • Korea Investment Corp reported no remaining Regenxbio position as of Q4 2021 after selling out during the quarter.
  • Korea Investment Corp sold 393,071 Regenxbio shares in Q4 2021, an estimated $16.5M.
  • Korea Investment Corp first reported a position in Regenxbio in Q2 2019 and held it in 10 quarters.
  • Korea Investment Corp's Regenxbio position peaked at $22.2M in Q4 2020.
  • 172 funds tracked by Wall St. Rank held Regenxbio as of Q4 2021.

Based on Korea Investment Corp's 13F filing for Q4 2021, filed 9 Feb 2022.